Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US10098877 | STRONGBRIDGE | Methods and compositions for treating diabetes, metabolic syndrome and other conditions |
Jan, 2026
(2 years from now) | |
US10835530 | STRONGBRIDGE | Methods and compositions for treating diabetes, metabolic syndrome and other conditions |
Jan, 2026
(2 years from now) | |
US10517868 | STRONGBRIDGE | Methods and compositions for treating diabetes, metabolic syndrome and other conditions |
Jan, 2026
(2 years from now) | |
US9918984 | STRONGBRIDGE | Methods and compositions for treating diabetes, metabolic syndrome and other conditions |
Jan, 2026
(2 years from now) | |
US11478471 | STRONGBRIDGE | NA |
Jan, 2026
(2 years from now) | |
US11278547 | STRONGBRIDGE | Methods of treating disease with levoketoconazole |
Mar, 2040
(16 years from now) | |
US11020393 | STRONGBRIDGE | Methods of treating disease with levoketoconazole |
Mar, 2040
(16 years from now) |
Exclusivity | Exclusivity Expiration |
---|---|
Orphan Drug Exclusivity (ODE) | Dec 30, 2028 |
Drugs and Companies using LEVOKETOCONAZOLE ingredient
Market Authorisation Date: 30 December, 2021
Treatment: Treatment of endogenous hypercortisolemia in patients with cushing’s syndrome for whom surgery is not an option or has not been curative; During levoketoconazole dosage titration for the treatment of ...
Dosage: TABLET;ORAL
13
United States
3
Korea, Republic of
2
Australia
2
Israel
2
Canada
2
Japan
2
China
2
European Union
1
IB
1
New Zealand
1
Denmark
1
Spain
1
Austria
1
Cyprus
1
Portugal
1
Poland
1
Norway
1
Hong Kong
1
Slovenia
1
Mexico
1
South Africa
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic